Mehri Mashayekhi
Department of Endocrinology and Female Infertility · Department of Endocrinology and Female Infertility, ACECR, Tehran, Iran. · Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mehri Mashayekhi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:13 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06199960 · Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian RespondersRoyan Institute · completed · Assisted Reproductive Techniques · principal investigator
- N/ANCT04855383 · Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer CyclesRoyan Institute · completed · Embryo Implantation · study director
- Ph1/Ph2NCT02603744 · Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF)Royan Institute · unknown · Premature Ovarian Failure · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:13 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- 86 citationsRCR 10.3
- 62 citationsRCR 4.7
- Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals With Obesity and Prediabetes.Diabetes · 202455 citationsRCR 9.0
- Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice.Int J Clin Pharm · 201853 citationsRCR 3.8
- Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.Diabetes Obes Metab · 202333 citationsRCR 3.7
- GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans.Hypertension · 202132 citationsRCR 2.1
- Association of a glucagon-like peptide-1 receptor gene variant with glucose response to a mixed meal.Diabetes Obes Metab · 202117 citationsRCR 1.0
- 7 citationsRCR 0.6
- 6 citationsRCR 1.8
- RISING STARS: Effects of a GLP-1 receptor polymorphism on responses to liraglutide.J Endocrinol · 20254 citationsRCR 1.2